Issue navigation
Volume 62, Issue 6, June 2023
EDITORIALS
Is the parent global assessment a reliable quality of life measure in juvenile idiopathic arthritis?
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2023–2024, https://doi.org/10.1093/rheumatology/keac600
How to manage patients perceived as having a mild form of early arthritis?
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2025–2026, https://doi.org/10.1093/rheumatology/keac657
Good common sense and clinical judgment should be the driver for further investigation
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2027–2029, https://doi.org/10.1093/rheumatology/keac631
Clinical observation: are nightmares a manifestation of neuropsychiatric lupus?
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2030–2031, https://doi.org/10.1093/rheumatology/keac655
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targets
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2032–2034, https://doi.org/10.1093/rheumatology/keac697
Depression in spondyloarthritis: can we kill two birds with one stone?
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2035–2036, https://doi.org/10.1093/rheumatology/keac704
SYSTEMATIC REVIEW AND META ANALYSIS
A systematic review of the sex differences in risk factors for knee osteoarthritis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2037–2047, https://doi.org/10.1093/rheumatology/keac688
Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2048–2059, https://doi.org/10.1093/rheumatology/keac715
REVIEWS
Improving outcomes in scleroderma: recent progress of cell-based therapies
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2060–2069, https://doi.org/10.1093/rheumatology/keac628
Thrombocytopaenia in antiphospholipid syndrome: a free radical perspective
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2070–2075, https://doi.org/10.1093/rheumatology/keac650
CLINICAL SCIENCE
Comparison of health-care utilization, costs and health-related quality of life across the subgroups defined by the Keele STarT MSK Tool
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2076–2082, https://doi.org/10.1093/rheumatology/keac560
Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2083–2089, https://doi.org/10.1093/rheumatology/keac563
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2090–2097, https://doi.org/10.1093/rheumatology/keac564
Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2098–2105, https://doi.org/10.1093/rheumatology/keac582
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2106–2112, https://doi.org/10.1093/rheumatology/keac601
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2113–2121, https://doi.org/10.1093/rheumatology/keac607
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2122–2129, https://doi.org/10.1093/rheumatology/keac605
Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2130–2138, https://doi.org/10.1093/rheumatology/keac567
The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2139–2146, https://doi.org/10.1093/rheumatology/keac580
Trust in the attending rheumatologist, health-related hope and medication adherence among Japanese systemic lupus erythematosus patients
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2147–2153, https://doi.org/10.1093/rheumatology/keac565
Grit personality of physicians and achievement of treatment goals in patients with system lupus erythematosus
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2154–2159, https://doi.org/10.1093/rheumatology/keac612
‘I turned in my man card’: a qualitative study of the experiences, coping styles and support needs of men with systemic sclerosis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2160–2167, https://doi.org/10.1093/rheumatology/keac585
Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2168–2177, https://doi.org/10.1093/rheumatology/keac549
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2178–2188, https://doi.org/10.1093/rheumatology/keac576
Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2189–2196, https://doi.org/10.1093/rheumatology/keac566
Added diagnostic yield of temporal artery magnetic resonance angiography in the evaluation of giant cell arteritis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2197–2202, https://doi.org/10.1093/rheumatology/keac583
Angiotensin receptor blockade is associated with increased risk of giant cell arteritis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2203–2210, https://doi.org/10.1093/rheumatology/keac599
The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2211–2219, https://doi.org/10.1093/rheumatology/keac619
Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2220–2229, https://doi.org/10.1093/rheumatology/keac556
Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2230–2238, https://doi.org/10.1093/rheumatology/keac587
Comprehensive and reliable sonographic assessment and scoring system for inflammatory lesions of the paediatric ankle
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2239–2246, https://doi.org/10.1093/rheumatology/keac622
Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for gout
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2247–2251, https://doi.org/10.1093/rheumatology/keac590
Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2252–2256, https://doi.org/10.1093/rheumatology/keac596
External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumab
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2257–2261, https://doi.org/10.1093/rheumatology/keac618
Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still’s disease
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2262–2266, https://doi.org/10.1093/rheumatology/keac620
Relevance of leukaemia inhibitory factor to anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2267–2271, https://doi.org/10.1093/rheumatology/keac632
BASIC SCIENCE
Development of a scoring model for the Sharp/van der Heijde score using convolutional neural networks and its clinical application
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2272–2283, https://doi.org/10.1093/rheumatology/keac586
Autoimmune activation and hypersensitization of the AT1 and ETA receptors contributes to vascular injury in scleroderma renal crisis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2284–2293, https://doi.org/10.1093/rheumatology/keac594
Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2294–2303, https://doi.org/10.1093/rheumatology/keac574
Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2304–2311, https://doi.org/10.1093/rheumatology/keac581
Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with rheumatoid arthritis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2312–2319, https://doi.org/10.1093/rheumatology/keac598
WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2320–2324, https://doi.org/10.1093/rheumatology/kead006
A deep learning system for quantitative assessment of microvascular abnormalities in nailfold capillary images
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2325–2329, https://doi.org/10.1093/rheumatology/kead026
CORRECTION
Correction to: Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case–control study
Rheumatology, Volume 62, Issue 6, June 2023, Page 2331, https://doi.org/10.1093/rheumatology/kead043
LETTERS TO THE EDITOR
OTHERS
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies
Rheumatology, Volume 62, Issue 6, June 2023, Pages e175–e179, https://doi.org/10.1093/rheumatology/keac644
Utilization of electronic health record data to evaluate the association of urban environment with systemic lupus erythematosus symptoms
Rheumatology, Volume 62, Issue 6, June 2023, Pages e180–e181, https://doi.org/10.1093/rheumatology/keac647
Association between disability scores and opioid use in patients with psoriatic arthritis and ankylosing spondylitis
Rheumatology, Volume 62, Issue 6, June 2023, Pages e182–e184, https://doi.org/10.1093/rheumatology/keac673
COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes
Rheumatology, Volume 62, Issue 6, June 2023, Pages e185–e187, https://doi.org/10.1093/rheumatology/keac705
CASE REPORTS
Brain oedema due to disseminated intravascular coagulation in a patient with adult-onset Still’s disease–associated hemophagocytic lymphohistiocytosis—a case report
Rheumatology, Volume 62, Issue 6, June 2023, Pages e188–e190, https://doi.org/10.1093/rheumatology/keac595
Immune checkpoint inhibitor-induced radiation recall myositis
Rheumatology, Volume 62, Issue 6, June 2023, Pages e191–e192, https://doi.org/10.1093/rheumatology/keac636
A case of A20 haploinsufficiency in which intestinal inflammation improved with thalidomide
Rheumatology, Volume 62, Issue 6, June 2023, Pages e193–e195, https://doi.org/10.1093/rheumatology/keac634
A novel frameshift variant in TNFRSF13B in a Chinese patient with late-onset combined immunodeficiency
Rheumatology, Volume 62, Issue 6, June 2023, Pages e196–e198, https://doi.org/10.1093/rheumatology/keac681
MATTERS ARISING FROM PUBLISHED PAPERS
Comment on: Text neck misdiagnosed as fibromyalgia
Rheumatology, Volume 62, Issue 6, June 2023, Pages e199–e200, https://doi.org/10.1093/rheumatology/keac642
Comment on: Text neck misdiagnosed as fibromyalgia. Reply
Rheumatology, Volume 62, Issue 6, June 2023, Page e201, https://doi.org/10.1093/rheumatology/keac643
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
Rheumatology, Volume 62, Issue 6, June 2023, Pages e202–e203, https://doi.org/10.1093/rheumatology/keac648
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply
Rheumatology, Volume 62, Issue 6, June 2023, Page e204, https://doi.org/10.1093/rheumatology/keac649
CLINICAL VIGNETTES
Multicentric Castleman disease with trismus
Rheumatology, Volume 62, Issue 6, June 2023, Pages e205–e206, https://doi.org/10.1093/rheumatology/keac611
Bilateral sclerochoroidal calcification in a patient with calcium pyrophosphate deposition disease
Rheumatology, Volume 62, Issue 6, June 2023, Pages e207–e208, https://doi.org/10.1093/rheumatology/keac633
Ixekizumab-associated disseminated tinea corporis in a patient with psoriatic arthritis and plaque psoriasis
Rheumatology, Volume 62, Issue 6, June 2023, Pages e209–e210, https://doi.org/10.1093/rheumatology/keac635
